Abstract The delineation of clinical target volume (CTV) is a critical step in planning conformal radiotherapy for rectal cancer. Several guidelines suggest different subvolumes and anatomical boundaries in radiotherapy for rectal cancer, potentially leading to a misunderstanding of CTV definition. This article reviews recent advances in the delineation of CTV in radiotherapy for rectal cancer.
Yang Yongqiang,Zhu Yaqun,Tian Ye. Recent advances in delineation of clinical target volume in radiotherapy for rectal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(9): 1089-1093.
Yang Yongqiang,Zhu Yaqun,Tian Ye. Recent advances in delineation of clinical target volume in radiotherapy for rectal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(9): 1089-1093.
[1] Sauer R,Becker H,Hohenberger W,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med,2004,351(17):1731-1740.DOI:10.1056/NEJMoa040694. [2] 任骅,金晶,肖琴,等.直肠癌术前IMRT同期化疗与VMAT同期化疗的急性不良反应比较[J].中华放射肿瘤学杂志,2014,23(3):205-209.DOI:10.3760/cma.j.issn.1004-4221.2014.03.007. Ren H,Jin J,Xiao Q,et al. Comparison of acute toxicities between IMRT and VMAT in preoperative concurrent chemoradiotherapy for rectal cancer[J].Chin J Radiat Oncol,2014,23(3):205-209.DOI:10.3760/cma.j.issn.1004-4221.2014.03.007. [3] Zhu J,Liu FQ,Gu WL,et al. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage Ⅱ/Ⅲ rectal adenocarcinoma:results of a phase Ⅱ study[J].Radiat Oncol,2014,9:70.DOI:10.1186/1748-717X-9-70. [4] Li JL,Ji JF,Cai Y,et al. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer:a phase Ⅱ trial[J].Radiother Oncol,2012,102(1):4-9.DOI:10.1016/j.radonc.2011.07.030. [5] 肖林,黄蓉,游凯云,等.局部进展期直肠癌术前新辅助放化疗中VMAT的可行性研究[J].中华放射肿瘤学杂志,2014,23(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2014.01.003. Xiao L,Huang R,You KY,et al. Study on feasibility of preoperative neoadjuvant chemoradiotherapy based on volumetric modulated arc therapy for locally advanced rectal cancer[J].Chin J Radiat Oncol,2014,23(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2014.01.003. [6] 胡静,郭旗,杨咏强,等.直肠癌术后IMRT±化疗疗效及预后分析[J].中华放射肿瘤学杂志,2015,24(6):633-637.DOI:10.3760/cma.j.issn.1004-4221.2015.06.007. Hu J,Guo Q,Yang YQ,et al. Analysis of efficacy and prognostic factors of postoperative intensity-modulated radiotherapy with or without chemotherapy in rectal cancer[J].Chin J Radiat Oncol,2015,24(6):633-637.DOI:10.3760/cma.j.issn.1004-4221.2015.06.007. [7] Samuelian JM,Callister MD,Ashman JB,et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(5):1981-1987.DOI:10.1016/j.ijrobp.2011.01.051. [8] Fuller CD,Nijkamp J,Duppen J,et al. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting[J].Int J Radiat Oncol Biol Phys,2011,79(2):481-489.DOI:10.1016/j.ijrobp.2009.11.012. [9] Nijkamp J,de Haas-Kock DFM,Beukema JC,et al. Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands[J].Radiother Oncol,2012,102(1):14-21.DOI:10.1016/j.radonc.2011.08.011. [10] Roels S,Duthoy W,Haustermans K,et al. Definition and delineation of the clinical target volume for rectal cancer[J].Int J Radiat Oncol Biol Phys,2006,65(4):1129-1142.DOI:10.1016/j.ijrobp.2006.02.050. [11] Myerson RJ,Garofalo MC,El Naqa I,et al. Elective clinical target volumes for conformal therapy in anorectal cancer:a radiation therapy oncology group consensus panel contouring atlas[J].Int J Radiat Oncol Biol Phys,2009,74(3):824-830.DOI:10.1016/j.ijrobp.2008.08.070. [12] Valentini V,Gambacorta MA,Barbaro B,et al. International consensus guidelines on Clinical Target Volume delineation in rectal cancer[J].Radiother Oncol,2016,120(2):195-201.DOI:10.1016/j.radonc.2016.07.017. [13] Bosset JF,Horiot JC,Hamers HP,et al. Postoperative pelvic radiotherapy with or without elective irradiation of Para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group[J].Radiother Oncol,2001,61(1):7-13.DOI:10.1016/S0167-8140(01)00419-4. [14] Xu BH,Guo YY,Chen YG,et al. Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?[J].Radiat Oncol,2015,10:257.DOI:10.1186/s13014-015-0566-6. [15] Joye I,Haustermans K.Clinical target volume delineation for rectal cancer radiation therapy:time for updated guideline?[J].Int J Radiat Oncol Biol Phys,2014,91(4):690-1691.DOI:10.1016/j.ijrobp.2014.11.006. [16] Nijkamp J,Kusters M,Beets-Tan RG,et al. Three-dimensional analysis of recurrence patterns in rectal cancer:the cranial border in hypofractionated preoperative radiotherapy can be lowered[J].Int J Radiat Oncol Biol Phys,2011,80(1):103-110.DOI:10.1016/j.ijrobp.2010.01.046.
2017, Vol. 26 
